| abstract |
This invention is providing the compound which can be used as an active ingredient of an anticancer agent. Another object of the present invention is to provide a pyridinone compound or a salt thereof that targets DOCK1 and can selectively inhibit it in view of providing an anticancer agent with few side effects. The pyridinone compound of the present invention has the following formula (1) [Chemical 1] (In the formula, R 1 and R 2 are the same or different and represent a C 1-6 alkyl group. R 3 is a group represented by the following formula (3) or the like). [Chemical 2] [In the group represented by the formula (3), R 5 represents a hydrogen atom or the like. ]) It is represented by |